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The Journal of Comorbidity was launched in 2011 and has 
since become established as a high-quality journal that 
publishes open-access, peer-reviewed articles, with a 
focus on advancing the clinical management of patients 
with comorbidity/multimorbidity. To further enhance 
research quality and reporting of studies in this field, 
the journal is now offering authors the opportunity to 
publish a summary of their study protocols – a move 
designed to generate interest and raise awareness in 
ongoing clinical research and to enable researchers to 
detail their methodologies in order that replication by 
scientific peers is possible.
Study protocols are a fundamental component of any 
study and provide insight into the thinking behind the 
study and how it will be conducted prior to its initiation. 
Protocols should meet the information needs of all stake-
holders, including researchers, funding agencies, ethical 
reviewers, regulators, medical journals, and systematic 
reviewers [1]. They should provide a comprehensive 
overview of all aspects of the study conduct and contain 
a summary of roles and responsibilities, the rationale and 
study objectives, a full description of the study design, 
including study settings, sample size, eligibility criteria, 
interventions and timelines, data collection and statisti-
cal methodologies, data monitoring, and dissemination 
policies [1]. For studies investigating issues relating to 
comorbidity/multimorbidity, protocols should clearly 
define the comorbid or multimorbid conditions under 
investigation and outline any restrictions based on pre-
determined lists of conditions [2]; they should explain 
how any proposed interventions will address these 
conditions [3], and they should outline how the study 
will overcome issues relating to generalizability and/
or external validity that can complicate comorbidity/
multimorbidity studies [4]. When developing a protocol 
for a cohort study, ideally using a prospective design, 
consideration should be given to how the study might 
enhance understanding of the natural history and tra-
jectory of the comorbid/multimorbid conditions, illness 
and treatment burden, patient quality of life and well-
being, as well as the quality, safety, and cost-effectiveness 
of care [5].
Why publish study protocols?
Publishing study protocols serves several important 
purposes. Publication increases research quality and 
transparency, encourages communication and collabo-
ration between research teams, helps to disseminate 
contemporary ideas about study design and data anal-
ysis, avoids research duplication, and may assist study 
recruitment.
The availability of a published final protocol allows 
subsequent authors and reviewers to cross-reference 
the study details, assists in presenting the final results, 
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aids systematic evaluation of the data, and discourages 
reporting bias. Importantly, it enables readers to com-
pare the original aims and design of the study with the 
final reported outcomes, thereby reducing the potential 
for unexplained post-hoc revisions of the study goals and 
methodologies – a problem that appears to affect the 
reporting of both observational studies and randomized 
controlled trials.
Publication of study protocols in peer-reviewed 
journals rightfully engenders the expectation that the 
results will eventually be disseminated, and encour-
ages investigators to report their findings in a timely 
and appropriate way. Last, but not least, we believe 
that publication of study protocols recognizes the 
substantial amount of work that is required for their 
development, affording research professionals, who 
may otherwise remain unseen, an opportunity to pro-
mote their work.
Publishing your study protocol in the Journal 
of Comorbidity
 • The Journal of Comorbidity will peer review proto-
cols unless the study has received approval from an 
institutional review board (IRB)/ethics committee 
and has received peer-reviewed grant support from a 
major extramural funding body
 • The Journal of Comorbidity endorses the SPIRIT 
(Standard Protocol Items: Recommendations for 
Interventional Trials) Statement [1]. Authors are 
required to follow these guidelines when preparing 
their protocol, with specific attention being paid to the 
challenges of comorbidity/multimorbidity research.
Types of protocol
 • Protocols that describe the design of planned or 
ongoing research will be considered for publication
 • Protocols for any study design will be considered, 
including observational, qualitative, exploratory stud-
ies, experimental studies, and systematic reviews. We 
encourage the submission of protocols for studies that 
will evaluate specific aspects of clinical trial design
 • Study protocols should generally provide a detailed 
account of the hypothesis, rationale, contextual 
background, design/methodology, statistical consid-
erations, and analysis of the proposed research
 • Study protocols should be presented with sufficient 
detail to enable replication of the methods by others
 • Full details of the requirements for submitting a proto-
col are described in the journal’s guidelines to authors, 
which can be found online (www.jcomorbidity.com).
Benefits
 • Open access – freely available online for readers 
worldwide
 • Rapid publication
 • High visibility
 • Authors retain copyright
 • Adequate space for comprehensive protocol 
description1
 • Authors are not required to submit subsequent reports 
of their study to the journal; however, the editors 
encourage the authors to consider doing so.
Submit your protocol to the Journal of 
Comorbidity
 • We invite all researchers involved in work that is per-
tinent to comorbidity/multimorbidity to submit their 
study protocols to the Journal of Comorbidity
 • To submit your protocol to the Journal of Comorbidity, 
go to the submissions page to register or login (http://
www.jcomorbidity.com/index.php/test/user/register).
About the Journal of Comorbidity
The Journal of Comorbidity is an international, open-
access, peer-reviewed journal for the pathophysiology, 
diagnosis, prevention and management of patients with 
comorbidity/multimorbidity. The journal currently pub-
lishes original clinical and experimental research articles, 
treatment guidelines/policies, editorials, commentar-
ies, and critical review articles, as well as proceedings of 
congresses. Preference is given to articles that advance the 
clinical management of patients. The Editorial Board also 
welcomes ideas and suggestions for special issues dedicated 
to a unique theme. The journal provides immediate, per-
manent open access to its content on the principle that 
making research freely available to the public supports a 
greater global exchange of knowledge.
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